Concurrent Investment Advisors LLC Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Concurrent Investment Advisors LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.3% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 13,150 shares of the medical equipment provider's stock after purchasing an additional 1,005 shares during the period. Concurrent Investment Advisors LLC's holdings in Intuitive Surgical were worth $6,513,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in ISRG. Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares during the last quarter. Bank Pictet & Cie Europe AG grew its position in Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after buying an additional 883 shares during the period. Proficio Capital Partners LLC increased its holdings in Intuitive Surgical by 70.9% during the fourth quarter. Proficio Capital Partners LLC now owns 1,820 shares of the medical equipment provider's stock worth $950,000 after buying an additional 755 shares during the last quarter. Dana Investment Advisors Inc. raised its position in Intuitive Surgical by 4.8% in the fourth quarter. Dana Investment Advisors Inc. now owns 2,171 shares of the medical equipment provider's stock worth $1,133,000 after acquiring an additional 100 shares during the period. Finally, Inceptionr LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at about $567,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on ISRG shares. Barclays decreased their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Truist Financial reduced their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Piper Sandler decreased their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Royal Bank Of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $588.95.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director owned 6,371 shares of the company's stock, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 in the last ninety days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 0.6%

NASDAQ:ISRG traded up $3.14 during mid-day trading on Friday, hitting $543.74. 704,815 shares of the stock traded hands, compared to its average volume of 1,672,707. The business's 50-day moving average price is $537.11 and its 200 day moving average price is $536.83. The company has a market cap of $194.89 billion, a PE ratio of 79.73, a price-to-earnings-growth ratio of 5.78 and a beta of 1.64. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period last year, the firm earned $1.50 EPS. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.